The medication works best as part of a comprehensive approach combining healthy eating habits and regular physical activity
Weekly semaglutide injection associated with substantial weight loss in obesity Adults with obesity assigned the GLP-1 receptor agonist semaglutide experienced substantial weight loss compared with placebo, with more than half of participants losing 15% of body weight, according to data from the STEP 1 study
Thats why we have assembled a dedicated team of professionals who are passionate about making weight loss accessible and affordable to the residents of Nashville
Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, et al
The peptides stability and receptor binding efficacy are influenced by storage conditions, which can affect its conformational integrity and, consequently, its biological activity in preclinical models
However, clinical studies have consistently shown weight loss as a beneficial secondary effect , making Tirzepatide a valuable option for patients seeking both improved blood sugar control and support with sustainable weight management